- Home
- LVO vs CELU Comparison
LVO vs CELU Comparison
Compare LVO & CELU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LVO
- CELU
- Stock Information
- Founded
- LVO 2009
- CELU 2016
- Country
- LVO United States
- CELU United States
- Employees
- LVO N/A
- CELU N/A
- Industry
- LVO Restaurants
- CELU Biotechnology: Pharmaceutical Preparations
- Sector
- LVO Consumer Discretionary
- CELU Health Care
- Exchange
- LVO Nasdaq
- CELU Nasdaq
- Market Cap
- LVO 61.3M
- CELU 49.8M
- IPO Year
- LVO N/A
- CELU N/A
- Fundamental
- Price
- LVO $0.72
- CELU $1.79
- Analyst Decision
- LVO Strong Buy
- CELU
- Analyst Count
- LVO 1
- CELU 0
- Target Price
- LVO $1.50
- CELU N/A
- AVG Volume (30 Days)
- LVO 337.0K
- CELU 63.1K
- Earning Date
- LVO 06-18-2025
- CELU 05-08-2025
- Dividend Yield
- LVO N/A
- CELU N/A
- EPS Growth
- LVO N/A
- CELU N/A
- EPS
- LVO N/A
- CELU N/A
- Revenue
- LVO $114,405,000.00
- CELU $54,220,000.00
- Revenue This Year
- LVO N/A
- CELU $23.29
- Revenue Next Year
- LVO N/A
- CELU N/A
- P/E Ratio
- LVO N/A
- CELU N/A
- Revenue Growth
- LVO N/A
- CELU 138.11
- 52 Week Low
- LVO $0.55
- CELU $1.00
- 52 Week High
- LVO $1.82
- CELU $5.22
- Technical
- Relative Strength Index (RSI)
- LVO 42.30
- CELU 44.46
- Support Level
- LVO $0.77
- CELU $1.78
- Resistance Level
- LVO $0.92
- CELU $2.10
- Average True Range (ATR)
- LVO 0.08
- CELU 0.18
- MACD
- LVO -0.01
- CELU -0.06
- Stochastic Oscillator
- LVO 12.22
- CELU 10.50
About LVO LiveOne Inc.
LiveOne Inc, formerly LiveXLive Media Inc is a premium internet network devoted to live music and music-related video content. The company has been building an online destination for music fans to enjoy live performances from music venues and music festivals around the world, such as Rock in Rio, Outside Lands Music and Arts Festival, and Hangout Music Festival, as well as original content, artist exclusives, and industry interviews. The Company operates mainly through three segments, PodcastOne, Slacker, and Media Group, with a majority of its revenue derived from the Slacker segment.
About CELU Celularity Inc.
Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. It manages its operations through an evaluation of three distinct business segments which include Cell Therapy, Degenerative Disease, and bio-banking. The company generates the majority of its revenue from bio-banking segment.